MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015
暂无分享,去创建一个
Kyoung-Ho Song | Pyoeng Gyun Choe | Wan Beom Park | Ji Hwan Bang | Sang Won Park | Myoung-don Oh | Eu Suk Kim | Hong Bin Kim | L. Poon | M. Peiris | E. Lau | Ranawaka A.P.M Perera | P. G. Choe | N. Kim | M. Oh | W. Park | S. Park | Hong-Bin Kim | Eric H.Y. Lau | Malik Peiris | R.A.P.M. Perera | Long Wei Ronald Ko | Nam-Joong Kim | Leo L.M. Poon | K. Song | J. Bang | E. S. Kim
[1] Dae-Won Kim,et al. Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015 , 2015, Osong Public Health and Research Perspectives.
[2] A. Zohaib,et al. Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012–2015 , 2017, Emerging infectious diseases.
[3] F. Hayden,et al. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia , 2016, Emerging infectious diseases.
[4] W. Lim,et al. The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.
[5] Y. Guan,et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] J. Whitehead,et al. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol , 2015, SpringerPlus.
[7] S. Park,et al. Viral Load Kinetics of MERS Coronavirus Infection. , 2016, The New England journal of medicine.
[8] B. Bosch,et al. Geographic Distribution of MERS Coronavirus among Dromedary Camels, Africa , 2014, Emerging infectious diseases.
[9] Z. Memish,et al. Infectious Middle East Respiratory Syndrome Coronavirus Excretion and Serotype Variability Based on Live Virus Isolates from Patients in Saudi Arabia , 2015, Journal of Clinical Microbiology.
[10] D. Tyrrell,et al. The time course of the immune response to experimental coronavirus infection of man , 1990, Epidemiology and Infection.
[11] A. Tamin,et al. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus , 2016, Emerging infectious diseases.
[12] W. Cao,et al. Disappearance of antibodies to SARS-associated coronavirus after recovery. , 2007, The New England journal of medicine.
[13] Z. Memish,et al. Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] S. Perlman,et al. Antibody Response and Disease Severity in Healthcare Worker MERS Survivors , 2016, Emerging infectious diseases.
[15] E. Lau,et al. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea , 2015, Emerging infectious diseases.
[16] Y. Guan,et al. Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[17] J. Bae. Implementation of Quaternary Prevention in the Korean Healthcare System: Lessons From the 2015 Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea , 2015, Journal of preventive medicine and public health = Yebang Uihakhoe chi.
[18] P. G. Choe,et al. Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection , 2016, Journal of Korean medical science.